about
Noninfectious uveitis: strategies to optimize treatment compliance and adherencePachychoroid diseases of the maculaMassive bilateral serous retinal detachment in a case of hypertensive chorioretinopathy.Adult coats' disease successfully managed with the dexamethasone intravitreal implant (ozurdex®) combined with retinal photocoagulation.Crystalline subtype of pre-descemetic corneal dystrophySmoking and age-related macular degeneration: review and updateSafety and Efficacy of Ranibizumab in Macular Edema following Retinal Vein Occlusion.Serous macular detachment associated with dome-shaped macula and tilted disc.Intraretinal Hyperreflective Foci in Acquired Vitelliform Lesions of the Macula: Clinical and Histologic Study.Genetic systems for a new approach to risk of progression of diabetic retinopathy.Optical Coherence Tomography Angiography in Fovea Plana.Iris Atrophy: A Novel Sign of Repeated Self-inflicted Laser Pointer Maculopathy.Choroidal Thickness Influences Near-Infrared Reflectance Intensity in Eyes With Geographic Atrophy Due To Age-Related Macular Degeneration.FOVEAL EXUDATE AND CHOROIDAL NEOVASCULARIZATION IN ATYPICAL CASES OF MULTIPLE EVANESCENT WHITE DOT SYNDROME.How to Differentiate Myopic Choroidal Neovascularization, Idiopathic Multifocal Choroiditis, and Punctate Inner Choroidopathy Using Clinical and Multimodal Imaging Findings.Pattern dystrophy of the macula in a case of steinert diseaseAn Assessment of Vitreous Degeneration in Eyes with Vitreomacular Traction and Macular Holes.Oxidative stress and its downstream signaling in aging eyes.Pharmacovitrectomy.Update on intravitreal anti-tumor necrosis factor alpha therapies for ocular disorders.Posterior scleral bowing with choroidal nevus on enhanced-depth imaging optical coherence tomography.ASSESSMENT OF THE SIGNIFICANCE OF CYSTIC CHANGES AFTER EPIRETINAL MEMBRANE SURGERY WITH INTERNAL LIMITING MEMBRANE REMOVAL.Systematic study of retinal vein occlusion in young patients. Case report and review of the literature.The Evolution of Outer Retinal Tubulation, a Neurodegeneration and Gliosis Prominent in Macular Diseases.REGRESSION OF TYPE 2 NEOVASCULARIZATION INTO A TYPE 1 PATTERN AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.Choroidal thickness and visual prognosis in type 1 lesion due to neovascular age-related macular degeneration.Safety of bilateral same-day intravitreal injections of anti-vascular endothelial growth factor agents.Intravitreal therapies for non-neovascular age-related macular degeneration with intraretinal or subretinal fluid.Functional impact of treatment with ranibizumab under a reactive strategy in patients with neovascular age-related macular degeneration.Clinical Characteristics, Choroidal Neovascularization, and Predictors of Visual Outcomes in Acquired Vitelliform Lesions.Intravitreal docosahexaenoic acid in a rabbit model: preclinical safety assessment.Clinical Characteristics and Treatment Outcomes of Recurrent Central Retinal Vein Occlusions.DELAYED-ONSET BILATERAL DIFFUSE UVEAL MELANOCYTIC PROLIFERATION ASSOCIATED WITH GASTRIC ADENOCARCINOMA.Enhanced Oxidative Stress and Other Potential Biomarkers for Retinopathy in Type 2 Diabetics: Beneficial Effects of the Nutraceutic Supplements.Aflibercept in exudative age related macular degeneration refractory to ranibizumab.Haemorrhagic retinopathy in visceral leishmaniasis complicating human inmunodeficiency virus infection.INTRAVITREAL DEXAMETHASONE IMPLANT FOR THE TREATMENT OF REFRACTORY MACULAR EDEMA IN RETINAL VASCULAR DISEASES: Results of the KKESH International Collaborative Retina Study Group.Macular retinal and choroidal thickness in unilateral relentless placoid chorioretinitis analyzed by swept-source optical coherence tomography.Local safety of repeated intravitreal Ozurdex.Clinicopathologic Correlation of Anti-Vascular Endothelial Growth Factor-Treated Type 3 Neovascularization in Age-Related Macular Degeneration.
P50
Q26796467-E126F0B7-CC1B-454B-BB27-27223E40EA69Q26821878-5D4FB043-8C6F-4840-AEDB-A38975AFD502Q34023461-097A13E8-680B-497F-9DAC-2CF75B909E7CQ34252617-8D820493-1A00-441D-93BF-BC7212471558Q34272368-5C9F6381-0420-4EA4-AD33-6191E4FA9F0BQ34394380-260807AB-8017-4510-9B26-54A607B8FFAEQ34708262-749B950A-6ADC-47E9-BF4D-C56E2F6901C8Q35546291-09C5A4EC-6489-4CC9-AB47-2551DC9F345EQ35921586-CDDB5296-7F8E-4F81-9ED7-565BCB4EFCCFQ35947170-38965945-C563-463F-BAC2-E695478A59E7Q36082009-C3142E9C-44BF-43EA-9F7A-E6E1FA110BEBQ36175865-5E93B3AA-114A-4E03-BDC5-6CA716C81246Q36205274-4261E8B2-2B69-4498-966C-9AA74B536479Q36252409-49CE5224-C50E-46EC-B79D-0681807C3D5AQ36309264-C4468E05-F7D4-4F7D-94F2-FD687C91FB5DQ37251295-CC537768-C3F4-46B0-859A-533FD4BB50F9Q37590832-51FD2581-D1BD-4B9F-9CE9-DD35D4E850D5Q37708674-2D96027D-7B7E-456E-AB32-B617F9A53F92Q38246744-D9E767E5-9D6F-46FD-8B20-5B4752561BE9Q38397111-ECFA92F2-8BB0-46B7-8961-CFF46B84C7EAQ38565957-AD273BF2-EA9A-46B3-819C-C838F4206E87Q38602147-AC2BD7DD-2B58-4CC3-9B5C-2C8049975076Q38680177-8E47FA25-13BA-4868-968C-759737BA3C7CQ38689408-6BD46E5D-7BE1-44C9-B24B-D2704980BBBCQ38954257-8BC6F9CC-B0F9-416F-9212-95AA5DEFB7A4Q38959057-C652BD11-C413-4B9A-8942-B2E21B95340DQ38959185-B8F2B32E-ED93-418F-98F8-C39C591CAACFQ39027454-2B333B57-CDB0-4423-AE98-22E3BCE8CF6FQ39280583-C0D05AF1-94A9-48F0-A1B8-77EAD342790DQ39377831-FA91D458-DC78-4316-9148-47A15689E27FQ39391488-25A30E5F-DAA8-4966-BE4B-BF0359D1A307Q39407810-35B8CD1E-2E66-45B9-A5E2-7426D02972F6Q40087590-85335C5D-AFCF-43F2-A0D6-F3C050FD1D1AQ40262807-EF8738C8-2878-4A0D-9CC1-E5D16013ABC3Q40377996-AE32C58A-151C-4356-9CA7-068D473F5A70Q40606925-17BA8CBF-9C02-4458-A24E-7F607941DA41Q40831027-AA6250F1-CAF4-43A7-B3C8-89010B23E3B1Q42130665-EEB9DB4C-0F7E-4D14-8C7E-911F4C335C68Q42395175-6C673C87-1B3F-4998-BBA1-8E61BA28DD14Q42516028-1D875081-43C8-4E95-9C69-34F30304798F
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Rosa Dolz-Marco
@ast
Rosa Dolz-Marco
@en
Rosa Dolz-Marco
@es
Rosa Dolz-Marco
@sl
type
label
Rosa Dolz-Marco
@ast
Rosa Dolz-Marco
@en
Rosa Dolz-Marco
@es
Rosa Dolz-Marco
@sl
prefLabel
Rosa Dolz-Marco
@ast
Rosa Dolz-Marco
@en
Rosa Dolz-Marco
@es
Rosa Dolz-Marco
@sl
P106
P1153
36496840400
P21
P31
P496
0000-0002-2963-2541